Study site | Site A | Site B | Site C |
---|---|---|---|
Prior exposure to KEMRI | Less | Less | More |
Perceived ease on recruitment/amount of CE activities | Harder/more CE | Easier/moderate CE | Easier/less CE |
CE and consent process changes (across sites) | • Provider of initial trial information: more by CHWs but less detailed | ||
• Provider of detailed study information: more by experienced facilitators and clinicians | |||
• Disclosure setting of initial trial information: more in community than in homes | |||
• Consent setting: more in facilities than in homes | |||
• Time consent is sought: closer to time of recruitment; less time for intra and inter family consultation and discussion | |||
 | • Administration of consent: less access in advance to consent forms with ‘scary wording’ |